biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Denali & Bioasis why not

<< Previous

Bullboard Posts

Next >>

Comment by MineDiggeron Jul 29, 2021 5:18am

117 Views

Post# 33619692

RE:RE:RE:Denali & Bioasis why not

re "BTI has a long history of not executing. ..."

Yes, but apart from that :)

surely it is still worth more of a punt given the valuation disparity, if you knew about the claimed better delivery!

Although when I look at my opportunity cost I can see the other viewpoint.

MD

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario